ImmuPharma PLC (IMM) — Net Asset Momentum
ImmuPharma PLC (IMM) recorded a net asset momentum of -151.4% as of December 2024, with net assets of GBX-542.86K GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of ImmuPharma PLC to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
ImmuPharma PLC Net Asset Momentum (2004–2024)
This chart tracks ImmuPharma PLC's year-over-year net asset growth across 22 annual reporting periods from 2004 to 2024. The most recent momentum reading is -151.4%, with net assets of GBX-542.86K GBX as of December 2024. Read total liabilities of ImmuPharma PLC for a breakdown of total debt and financial obligations.
Annual Net Asset History for ImmuPharma PLC (2004–2024)
The table below shows the complete annual net asset history for ImmuPharma PLC from 2004 to 2024, covering 22 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see IMM stock market capitalisation.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | GBX-542.86K | GBX977.01K | GBX1.52 Million | ▼ -151.4% |
| 2023 | GBX1.06 Million | GBX2.72 Million | GBX1.67 Million | ▼ -58.1% |
| 2022 | GBX2.52 Million | GBX3.97 Million | GBX1.45 Million | ▼ -42.8% |
| 2021 | GBX4.41 Million | GBX6.00 Million | GBX1.58 Million | ▼ -54.3% |
| 2020 | GBX9.65 Million | GBX10.92 Million | GBX1.26 Million | ▲ +83.2% |
| 2019 | GBX5.27 Million | GBX5.80 Million | GBX531.87K | ▼ -30.9% |
| 2018 | GBX7.62 Million | GBX8.66 Million | GBX1.03 Million | ▲ +113.3% |
| 2017 | GBX3.57 Million | GBX5.02 Million | GBX1.44 Million | ▼ -35.5% |
| 2016 | GBX5.55 Million | GBX6.71 Million | GBX1.16 Million | ▲ +228.1% |
| 2015 | GBX1.69 Million | GBX3.21 Million | GBX1.52 Million | ▼ -70.4% |
| 2014 | GBX5.71 Million | GBX7.07 Million | GBX1.37 Million | ▲ +5.6% |
| 2013 | GBX5.40 Million | GBX7.21 Million | GBX1.80 Million | ▼ -35.8% |
| 2012 | GBX8.42 Million | GBX10.51 Million | GBX2.09 Million | ▼ -32.7% |
| 2011 | GBX12.51 Million | GBX14.28 Million | GBX1.77 Million | ▼ -21.7% |
| 2010 | GBX15.97 Million | GBX17.55 Million | GBX1.58 Million | ▼ -11.7% |
| 2009 | GBX18.08 Million | GBX24.64 Million | GBX6.56 Million | ▲ +60.9% |
| 2008 | GBX11.24 Million | GBX13.40 Million | GBX2.16 Million | ▲ +268.5% |
| 2007 | GBX3.05 Million | GBX4.10 Million | GBX1.05 Million | ▼ -48.2% |
| 2006 | GBX5.89 Million | GBX7.33 Million | GBX1.44 Million | ▲ +135.1% |
| 2006 | GBX2.50 Million | GBX3.63 Million | GBX1.12 Million | ▲ +152.2% |
| 2005 | GBX993.00K | GBX1.01 Million | GBX14.00K | ▲ +1.5% |
| 2004 | GBX978.00K | GBX980.00K | GBX2.00K | — |